Sponsor study identifier
Secondary identifiers
interventional
420
1 country
1
Study Start
February 21, 2018
Actual (reported)Primary Completion
February 28, 2021
Actual (reported)Study Completion
February 28, 2021
Actual (reported)The central goal of this study is to identify the optimal approach to implementing an evidence-based practice facilitation (PF) intervention for the uptake and completion of HPV vaccine among adolescents receiving care in the community, guided by implementation science theory. AIM 1: Determine the clinical effectiveness and cost-effectiveness of two modalities for delivering a multi-component PF intervention to increase HPV vaccination initiation and completion in community-based pediatric practices. The investigators will compare the traditional In-person Coaching PF modality to a lower-resource Web-Based Coaching PF modality. The primary patient outcome is HPV vaccination. The investigators will also examine and compare the sustainability of practice changes on vaccination rates and the effects over time for each intervention modality. AIM 2. Understand mechanisms of why the PF intervention may work better for some pediatric practices than others for HPV vaccination. The investigators will examine theory-based determinants at the organizational, provider, and patient levels that may mediate (explain) or moderate (change) the effects of the PF intervention on vaccination outcomes.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
February 28, 2021
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
December 20, 2017
Actual (reported)January 16, 2018
Actual (reported)February 21, 2018
Actual (reported)February 28, 2021
Actual (reported)February 28, 2021
Actual (reported)Age-appropriate completion rate (ages 13-17)
Percentage of active patients ages 13-17 who completed the HPV vaccine series before 13th birthday
Annually, up to 3 years post baseline
Age-appropriate initiation rate (ages 13-17)
Monthly, up to 36 months post baseline
Age-appropriate completion rate (at age 13)
Monthly, up to 36 months post baseline
Age-appropriate initiation rate (at age 13)
Monthly, up to 36 months post baseline
Overall completion rate (ages 13-17)
Monthly, up to 36 months post baseline
Overall initiation rate (ages 13-17)
Monthly, up to 36 months post baseline
Documented recommendation rate (well visits)
Monthly, up to 36 months post baseline
Documented recommendation rate (all visits)
Monthly, up to 36 months post baseline
Bundling adolescent vaccines rate
Monthly, up to 36 months post baseline
Web-based delivery of practice facilitation for HPV vaccine
In-person delivery of practice facilitation for HPV vaccine
The practice facilitation intervention provides coaching support to pediatric practices to guide them through quality improvement projects to increase HPV vaccination rates.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Vanderbilt University Medical Center
Nashville, Tennessee, 37203, United States
Chang RS, Shing JZ, Erves JC, Du L, Koyama T, Deppen S, Rentuza AB, McAfee C, Stroebel C, Cates J, Harnack L, Andrews D, Bramblett R, Hull PC. Measurement of provider fidelity to immunization guidelines: a mixed-methods study on the feasibility of documenting patient refusals of the human papillomavirus vaccine. BMC Med Inform Decis Mak. 2022 Dec 22;22(1):339. doi: 10.1186/s12911-022-02083-2.
Pamela C Hull, PhD
Vanderbilt University Medical Center
420 participants (actual enrollment reported by the registry).
HPV Ends Here: Increasing Uptake of the HPV Vaccine
Contact the study team to confirm eligibility.
First Submitted
December 20, 2017
First Posted
January 16, 2018
Study Start
February 21, 2018
Actual (reported)Primary Completion
February 28, 2021
Actual (reported)Study Completion
February 28, 2021
Actual (reported)Last Updated
December 5, 2023
Record last verified: 2023-12
Data collected from providers and staff (surveys and interviews) will be made available to other researchers upon request. All individual identifiers will be stripped to ensure confidentiality and privacy of study participants.
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: